This trial is active, not recruiting.

Conditions infection, pneumonia, sepsis, cross infection
Sponsor Herlev Hospital
Start date December 2002
End date September 2005
Trial size 549 participants
Trial identifier NCT00197847, KA 02071


Purpose of the study is to investigate and quantify known and possible new riskfactors for nosocomiel infection and death in the intensive care setting.

As new riskfactors Mannose Binding Lechtin and Procalcitonin are chosen and compared to established riskfactors.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model defined population
Time perspective longitudinal

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria:Admission to ICU - Exclusion Criteria:Absence of informed consent and age less than 18 years -

Additional Information

Principal investigator Dorthe H Olsen, M.D.
Trial information was received from ClinicalTrials.gov and was last updated in September 2005.
Information provided to ClinicalTrials.gov by Herlev Hospital.